1048345-76-1Relevant articles and documents
Integrated strategies for identifying leads that target the ns3 helicase of the hepatitis C virus
LaPlante, Steven R.,Padyana, Anil K.,Abeywardane, Asitha,Bonneau, Pierre,Cartier, Mireille,Coulombe, René,Jakalian, Araz,Wildeson-Jones, Jessi,Li, Xiang,Liang, Shuang,McKercher, Ginette,White, Peter,Zhang, Qiang,Taylor, Steven J.
, p. 2074 - 2090 (2014/04/03)
Future treatments for individuals infected by the hepatitis C virus (HCV) will likely involve combinations of compounds that inhibit multiple viral targets. The helicase of HCV is an attractive target with no known drug candidates in clinical trials. Here
